Efficacy and Safety of Vodobatinib in Patients (pts) with Chronic Phase Philadelphia Positive Chronic Myeloid Leukemia (Ph+ CML): A Sub Group Analysis By Lines of Tyrosine Kinase Inhibitor (TKI) Therapy

Saved in:
Bibliographic Details
Published inBlood Vol. 140; no. Supplement 1; pp. 205 - 207
Main Authors Cortes, Jorge E., Saikia, Tapan, Kim, Dong-Wook, Alvarado, Yesid, Nicolini, Franck E., Rathnam, Krishnakumar, Khattry, Navin, Punatar, Sachin, Apperley, Jane F., Charbonnier, Aude, Deininger, Michael, de Lavallade, Hugues, Granacher, Nikki, Gambacorti-Passerini, Carlo, Lucchesi, Alessandro, Mauro, Michael, Vandenberghe, Peter, Verhoef, Gregor, Whiteley, Andrew R., Nag, Arijit, Apte, Shashikant, Yao, Siu-Long, Inamdar, Sandeep, Dillu, Ruchika Irene, Sreenivasan, Jayasree, Chimote, Geetanjali
Format Journal Article
LanguageEnglish
Published Elsevier Inc 15.11.2022
Online AccessGet full text

Cover

Author Nicolini, Franck E.
Yao, Siu-Long
Cortes, Jorge E.
Whiteley, Andrew R.
de Lavallade, Hugues
Verhoef, Gregor
Gambacorti-Passerini, Carlo
Apte, Shashikant
Vandenberghe, Peter
Kim, Dong-Wook
Mauro, Michael
Punatar, Sachin
Rathnam, Krishnakumar
Sreenivasan, Jayasree
Deininger, Michael
Lucchesi, Alessandro
Nag, Arijit
Inamdar, Sandeep
Apperley, Jane F.
Khattry, Navin
Alvarado, Yesid
Dillu, Ruchika Irene
Granacher, Nikki
Charbonnier, Aude
Chimote, Geetanjali
Saikia, Tapan
Author_xml – sequence: 1
  givenname: Jorge E.
  surname: Cortes
  fullname: Cortes, Jorge E.
  organization: Georgia Cancer Center, Augusta, GA
– sequence: 2
  givenname: Tapan
  surname: Saikia
  fullname: Saikia, Tapan
  organization: Prince Aly Khan Hospital, Mumbai, India
– sequence: 3
  givenname: Dong-Wook
  surname: Kim
  fullname: Kim, Dong-Wook
  organization: Uijeongbu Eulji Medical Center, Geumo-dong, Uijeongbu-si, Korea, Republic of (South)
– sequence: 4
  givenname: Yesid
  surname: Alvarado
  fullname: Alvarado, Yesid
  organization: Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
– sequence: 5
  givenname: Franck E.
  surname: Nicolini
  fullname: Nicolini, Franck E.
  organization: Centre Hospitalier Lyon Sud, LYON Cedex 03, France
– sequence: 6
  givenname: Krishnakumar
  surname: Rathnam
  fullname: Rathnam, Krishnakumar
  organization: Lake Area,Melur Main Rd, Meenakshi Mission Hospital and Research Centre, Tamil Nadu, India
– sequence: 7
  givenname: Navin
  surname: Khattry
  fullname: Khattry, Navin
  organization: Department of Bone Marrow Transplant, ACTREC, Tata Memorial Centre, Navi Mumbai, India
– sequence: 8
  givenname: Sachin
  surname: Punatar
  fullname: Punatar, Sachin
  organization: Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
– sequence: 9
  givenname: Jane F.
  surname: Apperley
  fullname: Apperley, Jane F.
  organization: Hammersmith Hospital, Imperial College, London, United Kingdom
– sequence: 10
  givenname: Aude
  surname: Charbonnier
  fullname: Charbonnier, Aude
  organization: Departement d'Hematologie, Institut Paoli Calmettes, Marseille, France
– sequence: 11
  givenname: Michael
  surname: Deininger
  fullname: Deininger, Michael
  organization: University of Utah, Salt Lake City, UT
– sequence: 12
  givenname: Hugues
  surname: de Lavallade
  fullname: de Lavallade, Hugues
  organization: King's College Hospital NHS Foundation, London, United Kingdom
– sequence: 13
  givenname: Nikki
  surname: Granacher
  fullname: Granacher, Nikki
  organization: Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium
– sequence: 14
  givenname: Carlo
  surname: Gambacorti-Passerini
  fullname: Gambacorti-Passerini, Carlo
  organization: Dept of Medicine and Surgery, University of Milano Bicocca, Monza, Italy
– sequence: 15
  givenname: Alessandro
  surname: Lucchesi
  fullname: Lucchesi, Alessandro
  organization: Hematology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy
– sequence: 16
  givenname: Michael
  surname: Mauro
  fullname: Mauro, Michael
  organization: Memorial Sloan Kettering Cancer Center, New York, NY
– sequence: 17
  givenname: Peter
  surname: Vandenberghe
  fullname: Vandenberghe, Peter
  organization: University of Leuven, Leuven, Belgium
– sequence: 18
  givenname: Gregor
  surname: Verhoef
  fullname: Verhoef, Gregor
  organization: Department of Hematology, UZ Leuven, Leuven, Belgium
– sequence: 19
  givenname: Andrew R.
  surname: Whiteley
  fullname: Whiteley, Andrew R.
  organization: Baylor University Medical Center, Dallas, TX
– sequence: 20
  givenname: Arijit
  surname: Nag
  fullname: Nag, Arijit
  organization: Tata Medical Center, Kolkata, India
– sequence: 21
  givenname: Shashikant
  surname: Apte
  fullname: Apte, Shashikant
  organization: Pune's Sahyadri Hospital, Maharashtra, India
– sequence: 22
  givenname: Siu-Long
  surname: Yao
  fullname: Yao, Siu-Long
  organization: Sun Pharmaceutical Industries, Inc., Princeton, NJ
– sequence: 23
  givenname: Sandeep
  surname: Inamdar
  fullname: Inamdar, Sandeep
  organization: Sun Pharma Advanced Research Company Ltd, Mumbai, India
– sequence: 24
  givenname: Ruchika Irene
  surname: Dillu
  fullname: Dillu, Ruchika Irene
  organization: Sun Pharma Advanced Research Company Ltd, Mumbai, India
– sequence: 25
  givenname: Jayasree
  surname: Sreenivasan
  fullname: Sreenivasan, Jayasree
  organization: Sun Pharma Advanced Research Company Ltd, Mumbai, India
– sequence: 26
  givenname: Geetanjali
  surname: Chimote
  fullname: Chimote, Geetanjali
  organization: Sun Pharmaceutical Industries, Inc., Princeton, NJ
BookMark eNp9UcGO0zAQtdAi0V34AG5zbIUCtpOYFE7dalmqzYpKW7hGjjNWBrJ2ZKeL8ot8FS5FHLnMzOG9mTfvXbIL5x0y9lrwt0JU8l07eN9lkkuZCaWKUj5jC1HKKuNc8gu24JyrrFi_Fy_YZYzfORdFLssF-3VjLRltZtCugwdtcZrBW_jmO9_qiRy1QA72aUQ3RViOU1zBT5p62PbBOzKw73XEVGnQHQ5jTxr2PtJET_gPcz_j4KmDGo8_8DEhlvv-DWzv69UH2MDDsYXb4I8jbJwe5kgRrmeoyWE8aTnMIe1zCHfkTqd2rqeWJh9gebjbreDQY9Dj_JI9t3qI-Opvv2JfP90ctp-z-svtbrupMyOqUmY2Pa6Vtbpc54WQlSpaVVgrhUy-dVWOVSEqW-XrVhRWGSWssWujjOxQ5UUr8ysmzntNkhUD2mYM9KjD3AjenMJo_oTRnMJozmEkzsczB5OwJ8LQRJMMNdhRQDM1naf_sH8DCp-Umg
CitedBy_id crossref_primary_10_3390_hemato4030017
crossref_primary_10_1080_17474086_2023_2234084
crossref_primary_10_1016_j_clml_2023_03_004
crossref_primary_10_1007_s11912_024_01502_z
crossref_primary_10_1080_14656566_2024_2331778
ContentType Journal Article
Copyright 2022 The American Society of Hematology
Copyright_xml – notice: 2022 The American Society of Hematology
DBID AAYXX
CITATION
DOI 10.1182/blood-2022-166452
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Biology
Anatomy & Physiology
EISSN 1528-0020
EndPage 207
ExternalDocumentID 10_1182_blood_2022_166452
S0006497122016275
GroupedDBID ---
-~X
.55
1CY
23N
2WC
34G
39C
4.4
53G
5GY
5RE
5VS
6J9
AAEDW
AAXUO
ABOCM
ABVKL
ACGFO
ADBBV
AENEX
AFOSN
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BAWUL
BTFSW
CS3
DIK
DU5
E3Z
EBS
EJD
EX3
F5P
FDB
FRP
GS5
GX1
IH2
K-O
KQ8
L7B
LSO
MJL
N9A
OK1
P2P
R.V
RHF
RHI
ROL
SJN
THE
TR2
TWZ
W2D
W8F
WH7
WOQ
WOW
X7M
YHG
YKV
ZA5
0R~
0SF
AALRI
AAYXX
ADVLN
AFETI
AITUG
AKRWK
CITATION
H13
ID FETCH-LOGICAL-c1852-f432a6ffa593412864b64ff212664d83e8418f839b14f6c61fcf9c6c2de634b23
IEDL.DBID ABVKL
ISSN 0006-4971
IngestDate Thu Sep 12 17:25:28 EDT 2024
Fri Feb 23 02:36:51 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue Supplement 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1852-f432a6ffa593412864b64ff212664d83e8418f839b14f6c61fcf9c6c2de634b23
OpenAccessLink https://doi.org/10.1182/blood-2022-166452
PageCount 3
ParticipantIDs crossref_primary_10_1182_blood_2022_166452
elsevier_sciencedirect_doi_10_1182_blood_2022_166452
PublicationCentury 2000
PublicationDate 2022-11-15
PublicationDateYYYYMMDD 2022-11-15
PublicationDate_xml – month: 11
  year: 2022
  text: 2022-11-15
  day: 15
PublicationDecade 2020
PublicationTitle Blood
PublicationYear 2022
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
SSID ssj0014325
Score 2.446676
SourceID crossref
elsevier
SourceType Aggregation Database
Publisher
StartPage 205
Title Efficacy and Safety of Vodobatinib in Patients (pts) with Chronic Phase Philadelphia Positive Chronic Myeloid Leukemia (Ph+ CML): A Sub Group Analysis By Lines of Tyrosine Kinase Inhibitor (TKI) Therapy
URI https://dx.doi.org/10.1182/blood-2022-166452
Volume 140
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxEB61qXhcEKQgCqWaA0IJaJXsy97tLYlatSRBQaRVbyt7bSsrwInaFGn_Ir-K8T6qVoILt93VWrY8o_nm5c8A7yUjVB4q4TEuYy_KE99LleIeU5KHnMshFy6hP__Czi6iz1fx1Q5M2rMwrq2ysf21Ta-sdfNl0OzmYFMU7owvwWnK_YAwzHHt7sJewNkw6MDeaHw5nd0VE6IwqC8yoODZDWiKm-RZD-ru8MC1tPvM1fj-Dk_3IOf0OTxrfEUc1ct5ATvadmF_ZClO_lniB6y6N6u0eBcejdunJ5P2DrcuPJ43pfN9-H3iyCJEXqKwCr8Jo7clrg1eUlwqSTy2kFhYXNQ8qzfY22xv-ujStNgQ6NJ8BHnoUjCOW3KzKgQuqp6vX_run3mpf6wLhTN9-52WIbC3WH3CyXzWP8YRkpnCKtuFLRkKjkucudZ7t5ZlSZtCLzgtrJvq3K4KSSbnGnvL6XkflzUFwku4OD1ZTs685iIHL3dnsz1DEhDMGBGnBJpBwiJSEWMINWnPVRLqJPITQ66a9CPDcuab3KQ5ywOlWRjJIHwFHbu2-jVgrIY5j42JNIXTuS-TVOtQG6GkomBehAfwsZVftqn5OrIqzkmCrBJ25oSd1cI-gKiVcPZA6TLCk38Pe_N_w97C01rRfM-PD6Gzvb7V78ij2cqjRmOPYHf6NfkD47z0hg
link.rule.ids 315,786,790,27602,27957,27958,45698
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6VVFAuFaQgCgXmgFACshK_1nZvSdQqIXYVCbfqzdr17ioW4ERtiuS_yK_qrB8VSHDhZlte7WpnNN-89luAD4IRKo8lt1ggfMvLQ9uKpAwsJkXgBoEYB9wk9JMLNr_0vlz713sw687CmLbK1vY3Nr221u2XUbubo21RmDO-BKdRYDuEYYZr9xHs07xR2IP9yfRqGT8UEzzXaS4yoODZDGiLm-RZj5rucMe0tNvM1Pj-Dk-_Qc75MzhsfUWcNMt5Dnuq7MPRpKQ4-UeFH7Hu3qzT4n14PO2eDmbdHW59eJK0pfMj-HVmyCJ4XiEvJX7lWu0q3Gi8orhUkHjKQmBR4qrhWb3FwXZ3O0STpsWWQJfmI8hDk4Ix3JLbdcFxVfd8_VQP_ySV-r4pJMbq7hstg-Ngtf6MsyQenuIEyUxhne3CjgwFpxXGpvXerCWtaFPoBZdFaaZalOtCkMm5wUG6XAwxbSgQXsDl-Vk6m1vtRQ5Wbs5mW5okwJnW3I8INJ2QeaQiWhNq0p7L0FWhZ4eaXDVhe5rlzNa5jnKWO1Ix1xOO-xJ65aZUrwB9Oc4DX2tPUTid2yKMlHKV5lJICua5ewyfOvll24avI6vjnNDJamFnRthZI-xj8DoJZ38oXUZ48u9hr_9v2Hs4mKdJnMWLi-UbeNoonW3Z_gn0djd36i15NzvxrtXee-Br9oo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficacy+and+Safety+of+Vodobatinib+in+Patients+%28pts%29+with+Chronic+Phase+Philadelphia+Positive+Chronic+Myeloid+Leukemia+%28Ph%2B+CML%29%3A+A+Sub+Group+Analysis+By+Lines+of+Tyrosine+Kinase+Inhibitor+%28TKI%29+Therapy&rft.jtitle=Blood&rft.au=Cortes%2C+Jorge+E.&rft.au=Saikia%2C+Tapan&rft.au=Kim%2C+Dong-Wook&rft.au=Alvarado%2C+Yesid&rft.date=2022-11-15&rft.pub=Elsevier+Inc&rft.issn=0006-4971&rft.eissn=1528-0020&rft.volume=140&rft.spage=205&rft.epage=207&rft_id=info:doi/10.1182%2Fblood-2022-166452&rft.externalDocID=S0006497122016275
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-4971&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-4971&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-4971&client=summon